Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Healthcare

Nureca Ltd PAT at Rs 36.19 crore in Q1FY22

Nureca Ltd has reported financial results for the period ended June 30, 2021.

  • By IPP Bureau | August 03, 2021

The company has reported a total income of Rs.121.62 crores during the period ended June 30, 2021, as compared to Rs.33.11 crores during the period ended March 31, 2021.  It reported a total income of Rs 30.38 crore during the period ended June 30, 2020.

It has posted a net profit / (loss) of Rs.36.19 crores for the period ended June 30, 2021, as against net profit / (loss) of Rs.3.89 crores for the period ended March 31, 2021.

It has reported EPS of Rs.36.20 for the period ended June 30, 2021, as compared to Rs.4.56 for the period ended March 31, 2021.  Financial Results (Q1 FY2021-22) - YoY Comparison

 The company has posted net profit / (loss) of Rs.36.19 crores for the period ended June 30, 2021, as against net profit / (loss) of Rs.9.44 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.36.20 for the period ended June 30, 2021, as compared to Rs.13.50 for the period ended June 30, 2020.

Nureca is engaged in the business of home healthcare and wellness products under Brand ``Dr Trust’’. It enables customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital-first company and sells its products through online channel partners such as e-commerce players, distributors and retailers. 

Upcoming E-conference

Other Related stories

Startup

Digitization